Effect of indomethacin on tumor invasion in human laryngeal cancer Hep-2 cells

AIM: To assess the effect of indomethacin on tumor invasion in a human laryngeal cancer Hep-2 cell line in vitro. METHODS: Hep-2 cells were exposed to indomethacin at different concentrations for 48 h. Then cell growth rate, the colony formation in soft agar medium and cell mobility were examined, and monolayer invasion assay was performed to assess cell invasion index. RESULTS: Preteatment with indomethacin inhibited the colony formation of Hep-2 cells and the cell mobility, and decreased the invasion index. CONCLUSION: Indomethacin can inhibit the invasion of Hep-2 cells.     

Effects of NF-κB decoy oligonucleotides on apoptosis in lung cancer cell A549

AIM: To investigate the effects of NF-κB decoy oligodeoxynucleotides (ODNs) on apoptosis in lung cancer cell A549. METHODS: The treatments of lung cancer cells (A549) were divided into three groups: group A (control group); group B (decoy ODN group) and group C (scramble decoy ODN group). FITC-labeled NF-κB decoy ODNs was transfected into A549 with LipofectAMINE^TM2000. The activation was observed by electrophoretic mobility shift assays (EMSA). The proliferation was observed by growth curve. The apoptosis of cells were observed by flow cytometry and TdT mediated dUTP-biotin Nick End Labeling (TUNEL). The expression of Bcl-2 and Fas were observed by Western blot. RESULTS: After FITC-labeled decoy ODNs was transfected for 1 hour, the decoy ODNs was detected in the nuclei of A549 cells. EMSA performed the depression of the NF-κB binding to the nucleus. The growth curve showed the inhibition of the A549 cell growth and the percentage of apoptosis was increased compare with control group by flow cytometry and TUNEL. The amount of apoptosis inhibitor (Bcl-2) in group A and group C were 2.0 times and 2.1 times more than that in group B, respectively. The level of apoptosis accelerator (Fas) in group B were 2.6 times and 2.3 times more than that in group A and group C, respectively via Western blot. CONCLUSION: The NF-κB decoy ODNs accelerate the apoptosis of lung cancer cell A549 and the mechanism may be due to its inhibiting the expression of Bcl-2 and increasing the level of Fas.     

鹅细小病毒VP2基因在大肠杆菌中的表达及纯化

将鹅细小病毒 (GPV) VP2基因插入原核表达载体 p PROEX- HTb,获得重组表达质粒 p PROEX- HTb- VP2。将其转化大肠杆菌 DH5α,用 IPTG诱导表达 ,表达菌体蛋白中可产生与预期大小相符的约 72 0 0 0的蛋白。以光密度扫描对该表达产物进行定量分析 ,表达产物约占菌体总蛋白的 14 %。经 His- tag金属螯合层析纯化 ,获得纯度较高的 6 His- VP2融合蛋白。 Western- blot结果表明 ,所得蛋白与鹅抗 GPV高免血清有较好的免疫反应性 ,说明在 VP2的 N端融合 6个组氨酸不影响其与特异抗体结合的活性。     

表达犬瘟热病毒H基因的重组犬2型腺病毒的构建与鉴定

将犬瘟热病毒 ( canine distemper virus,CDV ) H基因表达盒克隆入转移质粒 p VAXΔE3,构建含 CDV H基因表达盒的转移质粒 p VAXΔ E3L PH,用 Nru 和 Sal 分别酶切转移质粒 p VAXΔ E3L PH和犬 2型腺病毒全基因组质粒p Poly2 - CAV- 2 ,将 CDV H基因表达盒定向克隆入 p Poly2 - CAV- 2质粒中 ,构建 E3区部分缺失的包含 CDV H基因表达盒的犬 2型腺病毒重组质粒 p CAV- 2 / CDVL PH。 Asc 和 Cla 对 p CAV- 2 / CDVL PH进行双酶切 ,释放 CAV- 2 /CDVL PH重组基因组 ,利用脂质体将 CAV- 2 / CDVL PH重组基因组与去除 Sal 和 Nru 片段的 CAV- 2基因组两端片段共转染 DK细胞 ,盲传和重复转染 3次 ,4 d后出现典型 CAV- 2病变 ,获得重组病毒 CAV- 2 / CDVL PH。用 CDV H基因特异性引物经 RT- PCR扩增重组病毒 DK细胞培养物 ,能够扩增出相应的核酸片段 ,表明 CAV- 2 / CDVL PH在DK细胞繁殖的过程中能够转录 CDVL P H的 m RNA,重组病毒免疫犬 ,可以诱导犬产生特异的抗 CAV- 2 HI抗体和抗 CDV中和抗体     

IBDV地方变异株VP2基因的克隆与特性鉴定

应用 RT- PCR技术对 1株分离于地方免疫鸡群中暴发的传染性法氏囊病病例的传染性法氏囊病病毒 ( infec-tious bursal disease virus,IBDV) HN0 2 6株的 VP2基因进行了克隆与序列分析 ,并与相应毒株的 VP2高变区核苷酸及氨基酸序列进行了比较研究。结果表明 ,HN0 2 6株的核苷酸和氨基酸序列与变异株 Var- A的同源性最高 ,分别达97.3%和 97.6 % ;其次为超强毒株 UK6 6 1 ,分别为 95 .7%和 95 .2 % ;而和弱毒株 PBG98的同源率仅有 92 .8%和90 .3%。其中 ,在第一、二亲水区 ,HN0 2 6株均有 1个氨基酸发生了变化 ,即第 2 2 2位转变为 E、第 31 8位转变为 D。更重要的是 ,其 2 4 9位和 2 5 4位上的氨基酸分别为 K和 S,这些均为变异株的特性。另外 ,HN0 2 6株的七肽区保持SWSASGS不变 ,且第 2 79位和 2 84位氨基酸分别为 D和 A,又完全具备强毒株的特性。因此 ,初步确定所分离的HN0 2 6为有较强致病力的变异株 IBDV。     

猪瘟病毒E2(gp55)基因在昆虫细胞中的表达

将除去3'端跨膜区的猪瘟病毒E2基因亚克隆到杆状病毒转移载体pFastBacHTb,获得重组质粒pFBHT-E2,转化进含穿梭载体Bacmid的感受态细胞DH10Bac,发生转座作用,经抗性及蓝白斑筛选得到含E2基因的重组载体质粒rBacmid-E2,以脂质体介导的方法将此重组载体质粒转染sf9昆虫细胞,获得重组病毒,命名为rvBac-E2.经SDS-PAGE和Western-blot及ELISA等方法检测,结果表明,此E2基因在昆虫细胞中正确表达,表达的蛋白能与猪瘟阳性血清发生特异性反应.     

禽副粘病毒-2型标准毒株与不同分离株HN基因的序列测定及分析

提取实验室保存禽副粘病毒-2标准毒株Yucaipa株和3株分离毒株F4、F6、F8株的RNA，经RT—PCR，获得4株毒株的HN基因，同时测得F基因与HN基因之间的序列。序列分析结果表明，HN基因的ORF全长为1743 nt，编码一个由580个氨基酸组成的蛋白。运用DNAMAN软件分析，4株毒株与GenBank上已发表毒株的HN基因的核苷酸和氨基酸之间的同源性相比，同源率分别为99．89％和99．69％。分析F基因与HN基因间序列发现两基因间序列与副粘病毒科其他病毒的基因间序列相似，含有基因起始信号和终止信号，但不含3个碱基的连接序列。通过序列分析，在分子水平上进一步证实分离于同一批进口七彩文鸟的F4、F6株是抗原性存在差异的两个毒株。毒株间的血清学关系与分子水平的核苷酸序列、氨基酸序列的比较关系一致。     

Expression of the tobacco β-1,3-glucanase gene, PR-2d, following induction of SAR with Peronospora tabacina

Systemic acquired resistance (SAR) is induced following inoculation of Peronospora tabacina sporangia into the stems of Nicotiana tabacum plants highly susceptible to the pathogen. Previous results have shown that accumulation of acidic β-1,3-glucanases (PR-2's) following induction of SAR by P. tabacina may contribute to resistance to P. tabacina. We showed that up-regulation of the PR-2 gene, PR-2d, following stem inoculation with P. tabacina, is associated with SAR. Studies using plants transformed with GUS constructs containing the full length promoter from PR-2d or promoter deletions, provided evidence that a previously characterized regulatory element that is involved in response to salicylic acid (SA), may be involved in regulation of PR-2d following induction of SAR with P. tabacina. This work provides evidence that regulation of PR-2 genes during P. tabacina-induced SAR may be similar to regulation of these genes during infection of N-gene tobacco by TMV or following exogenous application of SA, and provides further support for the role of SA in regulation of genes during P. tabacina-induced SAR.     

鸭流感病毒4/2004-H6N2亚型毒株的血凝素基因全序列克隆与分析

2004初从正常鸭群中分离到一株鸭源禽流感病毒，命名为A／Duck／HN／4／2004(H6N2)。经对血凝素基因(HA)序列分析发现HA基因全长为1744bp，共编码566个氨基酸，在裂解位点仅含一个碱性氨基酸-精氨酸(R)，符合LPAIV的标准。将所得基因序列与已发表的同一亚型参考序列分析表明，与H6亚型流感HA基因同源性为89．2％-97．1％，经分子遗传演化分析表明本次分离株与香港分离株A／Duck／Hong Kong／3600／99(H6N2)、A／Duck／Hong Kong／3600／99(H6N2)最近。     

鸡白细胞介素2原核表达载体的构建及表达产物的鉴定

将鸡白细胞介素2(IL-2)的cDNA克隆到原核表达载体pET-30a( )上，构建原核重组表达质粒pET-IL-2，并在大肠杆菌BL21(DE3)中诱导表达，37℃用IPTG诱导3.5h后，SDS-PAGE检测表明，表达蛋白以包涵体的形式存在。将诱导后的工程菌超声波裂解，离心后的沉淀用PBS洗涤5～6次，得到高纯度的目的蛋白。